Literature DB >> 2080323

Cooling mediates the ventilatory depression associated with airflow through the larynx.

O P Mathew1, J W Anderson, G P Orani, F B Sant'Ambrogio, G Sant'Ambrogio.   

Abstract

Although constant airflow through the upper airway has been shown to induce ventilatory depression in anesthetized newborn animals, the role of laryngeal temperature in this response has not been studied. Experiments were performed in fourteen 1-5 day-old anesthetized puppies breathing through a tracheostomy. Tidal volume and laryngeal temperature were recorded while a constant stream of air (15-25 ml/sec) at room temperature was passed in the expiratory direction for 20 sec through the isolated upper airway. Warm (35-37 degrees C), humidified air at the same flow served as control. When laryngeal temperature was decreased by 7.5 +/- 0.9 degrees C, a marked change in breathing pattern was observed (VT = 54 +/- 5, TI = 187 +/- 33, TE = 636 +/- 179, VT/TI = 45 +/- 10% of control; n = 9). Warm air at the same flow induced no significant changes. Superior laryngeal nerve section abolished the effects of cooling on breathing pattern. In 5 puppies we compared the effect of 'fast' and 'slow' laryngeal cooling. Fast trials altered breathing pattern earlier than slow trials. We conclude that the depressant effect of airflow through the upper airway is entirely due to a decrease in laryngeal temperature and is mediated by superior laryngeal nerve afferents.

Entities:  

Mesh:

Year:  1990        PMID: 2080323     DOI: 10.1016/0034-5687(90)90105-8

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  2 in total

1.  Alteration of ventilatory activity by intralaryngeal CO2 in the cat.

Authors:  D Bartlett; S L Knuth; J C Leiter
Journal:  J Physiol       Date:  1992-11       Impact factor: 5.182

2.  Ventilatory and upper-airway resistance responses to upper-airway cooling and CO2 in anaesthetised rats.

Authors:  K D O'Halloran; A K Curran; A Bradford
Journal:  Pflugers Arch       Date:  1994-12       Impact factor: 3.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.